Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000196134 | SCV000249879 | uncertain significance | not provided | 2023-08-02 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Not located in the triple helical region, where the majority of pathogenic missense variants occur (Symoens et al., 2012; HGMD); This variant is associated with the following publications: (PMID: 27535533, 22696272) |
Labcorp Genetics |
RCV002229460 | SCV001504388 | likely benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-12-20 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002277487 | SCV002565666 | uncertain significance | Ehlers-Danlos syndrome | 2022-04-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336526 | SCV002642847 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2020-12-24 | criteria provided, single submitter | clinical testing | The p.A397T variant (also known as c.1189G>A), located in coding exon 8 of the COL5A1 gene, results from a G to A substitution at nucleotide position 1189. The alanine at codon 397 is replaced by threonine, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species, and threonine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |